Tepadina, Thioplex, Thiotepa (thiotepa) is a small molecule pharmaceutical. Thiotepa was first approved as Tepadina on 1982-01-01. It is used to treat adenocarcinoma, breast neoplasms, lymphoma, ovarian neoplasms, and sarcoma amongst others in the USA. It has been approved in Europe to treat hematopoietic stem cell transplantation and neoplasms. It is known to target cytochrome P450 2B6.
|Indication||adenocarcinoma, breast neoplasms, hematopoietic stem cell transplantation, lymphoma, neoplasms, ovarian neoplasms, sarcoma, urinary bladder neoplasms|
|Drug Class||Antineoplastics (thiotepa derivatives)|